Handok buys 20% share of Genexine

Published: 2012-09-28 06:56:00
Updated: 2012-09-28 06:56:00
Handok Pharmaceutical Co. Wednesday purchased 19.72 percent in shares of Genexine, a Korean biopharmaceutical company.

“Handok and Genexine already signed a memorandum of understanding in February to jointly develop new sustained release human growth hormone (GX-H9),” said Kim Young-jin, Chair...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.